Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69083844 | 6908384 | 4 | F | 20081119 | 20160822 | 20090212 | 20160822 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-14218549 | BRISTOL MYERS SQUIBB | 39.03 | YR | F | Y | 0.00000 | 20160822 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69083844 | 6908384 | 1 | PS | REYATAZ | ATAZANAVIR SULFATE | 1 | Oral | 300 MG, QD | 21567 | 300 | MG | CAPSULE, HARD | QD | ||||||
| 69083844 | 6908384 | 2 | SS | DIDANOSINE. | DIDANOSINE | 1 | Oral | 200 MG, QD | 438000 | MG | Y | 0 | 200 | MG | POWDER FOR ORAL SOLUTION | QD | |||
| 69083844 | 6908384 | 3 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 245 MG, QD | U | 0 | 245 | MG | QD | ||||||
| 69083844 | 6908384 | 4 | SS | RITONAVIR. | RITONAVIR | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 69083844 | 6908384 | 5 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, QD | 1 | DF | Y | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 69083844 | 6908384 | 1 | HIV infection |
| 69083844 | 6908384 | 2 | HIV infection |
| 69083844 | 6908384 | 3 | HIV infection |
| 69083844 | 6908384 | 4 | HIV infection |
| 69083844 | 6908384 | 5 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 69083844 | 6908384 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 69083844 | 6908384 | Caesarean section | |
| 69083844 | 6908384 | Live birth | |
| 69083844 | 6908384 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 69083844 | 6908384 | 1 | 2002 | 0 | ||
| 69083844 | 6908384 | 2 | 2002 | 20080630 | 0 | |
| 69083844 | 6908384 | 3 | 2002 | 0 | ||
| 69083844 | 6908384 | 4 | 2002 | 0 | ||
| 69083844 | 6908384 | 5 | 20080630 | 20080630 | 0 |